Midavaine, Elora
$1,200.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- —
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- October 1, 2018 – September 30, 2019
- Reference
- cihr-irsc:236-2018-2019-Q4-00231
Published purpose
Inhibition pharmacologique, génique et allostérique du récepteur chimiokinergique CCR2 contre la douleur cancéreuse osseuse et la prolifération tumorale
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions